Literature DB >> 7658809

Genetic testing in breast/ovarian cancer (BRCA1) families.

M Watson, V Murday, S Lloyd, B Ponder, D Averill, R Eeles.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7658809     DOI： 10.1016/s0140-6736(95)91424-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.

Authors:  A C DudokdeWit; A Tibben; H J Duivenvoorden; M F Niermeijer; J Passchier
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

Review 2.  Risk assessment and management of high risk familial breast cancer.

Authors:  D G R Evans; F Lalloo
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

3.  Attitudes towards cancer predictive testing and transmission of information to the family.

Authors:  C Julian-Reynier; F Eisinger; P Vennin; F Chabal; Y Aurran; C Noguès; Y J Bignon; M Machelard-Roumagnac; C Maugard-Louboutin; D Serin; B Blanc; P Orsoni; H Sobol
Journal:  J Med Genet       Date:  1996-09       Impact factor: 6.318

4.  Men in breast cancer families: a preliminary qualitative study of awareness and experience.

Authors:  M F McAllister; D G Evans; W Ormiston; P Daly
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

5.  Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup.

Authors:  A C DudokdeWit; A Tibben; H J Duivenvoorden; P G Frets; M W Zoeteweij; M Losekoot; A van Haeringen; M F Niermeijer; J Passchier
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

6.  An extended family suddenly confronted with a life-threatening hereditary arrhythmia.

Authors:  K S W H Hendriks; I M van Langen; J P van Tintelen; F J M Grosfeld; A A M Wilde; H F J Ten Kroode
Journal:  Neth Heart J       Date:  2005-09       Impact factor: 2.380

7.  Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.

Authors:  Brita Arver; Aina Haegermark; Ulla Platten; Annika Lindblom; Yvonne Brandberg
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

8.  Outcomes of multimodality breast screening for women at increased risk of familial breast cancer.

Authors:  Ian C Bennett; Jennifer Muller; Linda Cockburn; Helen Joshua; Gillian Thorley; Christine Baker; Nili Wood; Jane Brazier; Mark Jones; Nathan Dunn; Michael Gattas
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

9.  Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling.

Authors:  S Lloyd; M Watson; B Waites; L Meyer; R Eeles; S Ebbs; A Tylee
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.